ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
685
Frequently Asked Questions
What is Market Cap of Adma Biologics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Adma Biologics Inc market cap is $3.8B.
What is the 52-week high for Adma Biologics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adma Biologics Inc 52 week high is $25.67 as of September 21, 2025.
What is the 52-week low for Adma Biologics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adma Biologics Inc 52 week low is $13.50 as of September 21, 2025.
What is Adma Biologics Inc stock price today?
Adma Biologics Inc stock price today is $15.91.
What was Adma Biologics Inc stock price yesterday?
Adma Biologics Inc stock price yesterday was $16.16.
What is the PE ratio of Adma Biologics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Adma Biologics Inc’s P/E ratio is 18.73.
What is the Price-to-Book ratio of Adma Biologics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Adma Biologics Inc P/B ratio is 9.5615.
What is the 50-day moving average of Adma Biologics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Adma Biologics Inc 50-day moving average is $17.25.